Southern African HIV Clinicians Society

HIV News

Position statement of SAHCS on service delivery to TB patients (drug-susceptible and drug-resistant) during the COVID-19 pandemic
28 Mar 2020
Contributors: T Boyles, F Conradie, V Cox, A Grimsrud, J Hughes, J Nel, A Reuter, L Wilkinson

To support TB patients during the COVID-19 pandemic, it is critical both to patients and the healthcare system to minimise visits to health facilities. This document outlines key adaptations to the TB care service delivery that should be considered to reduce health facility visits during the COVID-19 pandemic. This guidance prioritises how to provide uninterrupted TB treatment in resource constrained health systems with a high burden of TB. In addition to outlining recommended service delivery approaches for drug-susceptible (DS-TB) and drug-resistant TB (DR-TB) patients, guidance on additional areas (including patient support, contact tracing, provision of the influenza vaccine, differentiating TB from COVID-19 and telephonic monitoring) is provided.
Clinical management of suspected or confirmed COVID-19 disease
27 Mar 2020
National Department of Health

Version 3
What people living with HIV need to know about HIV and COVID-19
26 Mar 2020
UNAIDS | 2020
Notice: Switching patients from Tenofovir 300mg/Emtricitabine 200mg back onto Abacavir/Lamivudine and Zidovudine 300mg/Lamivudine 150mg dual combination formulations
24 Mar 2020
Department of Health

Reference: 2020/03/13/AMD/EDP/01
COVID-19
11 Mar 2020
Recommendations from the Southern African HIV Clinicians Society (SAHCS) for COVID-19
Coronavirus disease 2019 (COVID-19) Quick Reference for Health Workers
11 Mar 2020
NICD

National Institute for Communicable Diseases (NICD)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
05 Mar 2020
Francesca Conradie, et al

Nix-TB Trial. Published in The New England Journal of Medicine
Editorial
05 Mar 2020
Guy Thwaites and Payam Nahid

Triumph and Tragedy of 21st Century Tuberculosis Drug Development. Published in The new England Journal of Medicine.
Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R
31 Dec 2019
Published in The New England Journal of Medicine
Essential Medical Guidance (EMGuidance)
27 Nov 2019
Please see the letter and instructions about how to access the guidelines via the EMGuidance mobile phone application.
UNAIDS data 2019
21 Jul 2019
This edition of UNAIDS data shows the results of some of the successes, but also the challenges that remain. It contains the very latest data on the world’s response to HIV, consolidating a small part of the huge volume of data collected, analysed and refined by UNAIDS over the years. The full data set of information for 1990 to 2018 is available on aidsinfo.unaids.org.
Interim guidance
18 Jul 2019
Interim guidance while abacavir/lamivudine, abacavir singles, lamivudine singles and abacavir/zidovudine (2nd Line) are out of stock updated 18.07.2019
Section 21 Reporting from Provinces
13 Nov 2018
NDoH

Please click on the link to download the template for patients on treatment and distribution of medicines. This document needs to be submitted to NDoH on a monthly basis by provinces in terms of usage of items obtained using bulk Section 21. Each province is required to collate different facility reports and submit their consolidated report every month.
FAQs for Dolutegravir & Women of Childbearing Potential: Interim Considerations
30 Oct 2018
IAS

Forum on the risks of preconception dolutegravir exposure
Interim guidance
11 Oct 2018
Interim guidance while abacavir/lamivudine, abacavir singles and lamivudine singles (2nd Line) are out of stock
Stockouts advice - AZT/3TC
20 Sep 2018
Interim guidance while abacavir/lamivudine, abacavir singles and lamivudine singles are out of stock
Statement issued Issued by the Stop Stockouts Project
24 Jul 2018
Reproductive health rights of women in South Africa under threat, as supply shortages leave health facilities across the country without supplies of contraceptives.
Statement by AfroCAB
17 Jul 2018
Statement by the African Community Advisory Board (AfroCAB) on Dolutegravir and neural tube defects in women living with HIV of child bearing age.
Optimising ART - July 2018
10 Jul 2018
Wits RHI

Monthly update shared with all members involved in projects aimed at optimising ART.
Optimising ART - June 2018
13 Jun 2018
Wits RHI

Monthly update shared with all members involved in projects aimed at optimising ART.
Healthcare in Protests, Violence & Conflict
01 Jun 2018
What you need to know
Guidance for Healthcare Worker Colleagues in the North West as facilities and medicine supply returns to normal
01 Jun 2018
For adults and paediatrics
Statement
19 May 2018
DTG in pregnancy
Statement
10 May 2018
North-West Province: A health system on its knees
Statement
29 Mar 2018
The Southern African Journal of HIV Medicine accepted onto PubMed Central®
Statement
15 Mar 2018
Statement on 5-FC for cryptococcal meningitis.
HIV Self-Screening
31 Dec 2017
What it is and how to integrate it into HIV Testing Services
South African HIV-patients with Low Level Viremia are at Risk for therapy Failure.
20 Nov 2017
In a large South African cohort study, a team of researchers from the University of the Witwatersrand (Johannesburg, Gauteng, South Africa), the Ndlovu Research Consortium (Groblersdal, Limpopo, SA), the National Health Laboratory Service (SA), the University of California San Diego (USA), and the University Medical Center Utrecht (The Netherlands) found that low level viremia in treated HIV-patients is an important risk factor for treatment failure.
Application form for third-line antiretroviral therapy - updated
13 Oct 2017
National Department of Health

Please find attached the application form that is required to be completed for access to Third Line Antiretroviral Therapy. Please complete the form using the following steps: • Download: Please download the PDF document. • Open: Open the PDF document using Adobe Reader. Ensure you have the latest version of the form may not work properly. • Fill: This is an editable PDF, and the minimum required fields will be highlighted. Please click on each field and enter the required patient information. Please do not print out the document to complete by hand. • Save: Once you have completed the document please save it to your computer by clicking the icon on the top left of the screen. Save it using the patient name and surname as a unique identifier. • Submit: Close Adobe and attach the completed and renamed application form to an email and submit it to the following email address: TLART@health.gov.za
Application form for third-line antiretroviral therapy
11 Jul 2017
National Department of Health

This TLART application form has been formatted to allow the data to be electronically extracted. The fields must be inputted electronically. There is no need for electronic signatures and the form to be 'closed' - this actually blocks the electronic extraction. You will note some fields are outlined in red. This however does not block the user from sending if they are not completed, but prompts you to fill in the minimum requirements.
Adherence and Drug Resistance explained
12 Dec 2016
A flipchart to highlight key points
National reflex CrAg screening in SA
09 Dec 2016
NICD

From 1 October 2016, labs across South Africa have “switched on” reflex CrAg screening. We expect to screen 250,000 people with CD4<100 per year across SA. This should improve early case detection. This is a significant milestone after many years of advocacy. Here’s a link to an online article targeted at the general public: http://theconversation.com/a-new-meningitis-screening-test-could-help-cut-south-africas-hiv-aids-deathtoll-69452
NHLS AIDS 2016 HE2RO Policy Brief: Towards 90-90-90
01 Dec 2016
How close is South Africa to reaching the UNAIDS HIV treatment targets?
Policy brief: HIV testing services
01 Dec 2016
World Health Organization

WHO recommends assistance for people with HIV to notify their partners
Policy brief: HIV testing services
01 Dec 2016
World Health Organization

WHO recommends HIV self-testing
Media release
23 Nov 2016
National Department of Health, National Health Laboratory Service, National Institute for Communicable Diseases, Right to Care

Groundbreaking data system set to accelerate HIV/Aids elimination in South Africa
90-90-90 Compendium
15 Nov 2016
Health Systems Trust

This first volume of the 90-90-90 Compendium is targeted at a wide range of readers in South Africa, including community members and/ or politicians with no medical background. It is designed to assist all health sector role-players in understanding the context of the 90-90-90 strategy, as developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS), and then the process for achieving the strategy’s targets.
Stop Stock Outs Project - 2015 Stock Outs National Survey
03 Oct 2016
Third Annual Report - South Africa
National HIV Testing Services: Policy 2016
29 Sep 2016
Prepared by the National Department of Health
NDoH Circular: Test and Treat
06 Sep 2016
Implementation of the universal Test and Treat strategy for HIV positive patients and differentiated care for stable patients
Evidence to Action IAS 2016 Satellite Session Programme
15 Jul 2016
The session is hosted by the Centre for Infectious Disease Epidemiology and Research (CIDER) in the School of Public Health & Family Medicine at the University of Cape Town; Anova Health Institute; the International Epidemiologic Databases to Evaluate AIDS network - Southern Africa (IeDEA-SA); ICAP at Columbia University; and the Southern African HIV Clinicians Society.
Standard treatment guidelines and essential medicines list for SA
06 Jul 2016
This is the latest version of the National Department of Health's "Standard treatment guidelines and essential medicines list for SA" - Hospital level adult edition.
2nd EMBO Workshop on AIDS-related mycoses
15 Jun 2016
This workshop on 13-15 July 2016 will be held at UCT and is ideal for anyone with a research, laboratory or clinical interest in fungal pathogens in HIV infected individuals.
DoH National Policy on PrEP
09 Jun 2016
The 2016 "National Policy on HIV Pre-exposure Prophylaxis (PrEP) and Test and Treat (T&T)" has been released by the SA National Department of Health
DoH PrEP guidelines for sex workers
09 Jun 2016
The 2016 "Guidelines for Expanding Combination Prevention and Treatment Options for Sex Workers: Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T&T)" have been released by the SA National Department of Health.
GlobalSHARE: Global Community for Sex, HIV And Reproductive Empowerment
10 May 2016
This is a shareable PDF with information about a new Global Community for Sex, HIV And Reproductive Empowerment/Global SHARE. This is a community of providers, civil society members and PLHIV who are interested in addressing the reproductive needs and rights of PLHIV.
AGM Voting Form
19 Apr 2016
Form attached
Proxy voting form
12 Apr 2016
Form attached
Discontinuation of Crixivan 400 mg capsules
07 Apr 2016
Letter
Board nominee summaries
01 Apr 2016
2016
Infectious Diseases Class
30 Mar 2016
Programme 2016
MOI 21 Nov
22 Mar 2016
Final document
Notice of AGM
22 Mar 2016
2016
The Southern African HIV Clinicians Society supports the decriminalisation of sex work
09 Mar 2016
The Southern African HIV Clinicians Society supports evidence-based law- and policy-making. We believe that South Africa will not reach our own, as well as international, HIV reduction and treatment targets or related public health goals if it does not decriminalise adult sex work.
Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection
08 Mar 2016
The aim of the this PrEP guideline is to explain what PrEP is, outline current indications for its use, outline steps for appropriate user selection and provide guidance to monitor and maintain PrEP users.
Corrigendum: 2015 Society PEP Guidelines
03 Mar 2016
This document is a corrigendum to our "Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update".
Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update
03 Mar 2016
This guideline is an update of the post-exposure prophylaxis (PEP) guideline published by the Southern African HIV Clinicians Society in 2008.
Board Nomination form
19 Feb 2016
This document contains all the information and the nomination form pertaining to the Society's 2016 board elections.
Call for Expression of Interest for Consideration to be part of the National Pharmacovigilance Centre Technical Support team
03 Feb 2016
EOI
NDoH Advisory: use of FDCs to reduce use of single-agent lamivudine tablets
07 Jan 2016
This document, and the associated circular (FDC ARV Circular, dated 25.05.2015) provides guidance on how to prescribe FDCs. This reduces the need to use single-agent lamivudine tablets.

HIV news